Bodenrader Mark

Officer at Cerevel Therapeutics Holdings, Inc.

Sold, on record
$389k
Dollars the filings state
Form 4 sales
2
Latest Dec 20, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Jun 2, 2023 2023

    Sold 1,895 shares at $32.95 ($62k)

    Bodenrader Mark, Officer

    10b5-1 planSold 25.5% of holdings ($244k position)5,522 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice Cerevel Therapeutics Holdings, Inc.Notice
    Jun 5, 2023 +3 days

    Filed to sell 1,895 shares ($62k)

    Bodenrader Mark, Officer

    No 10b5-1 planFiling

  3. Dec 20, 2023 +198 days

    Sold 7,889 shares at $41.42 ($327k)

    Bodenrader Mark, Officer

    No 10b5-1 planSold 30.8% of holdings ($1.1M position)17,724 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Bodenrader Mark
Source
Dec 20, 2023Dec 21, 2023Cerevel Therapeutics Holdings, Inc.OfficerForm 4 sale7,889$327k30.8%UnusualSEC
Jun 5, 2023Jun 5, 2023Cerevel Therapeutics Holdings, Inc.OfficerForm 144 notice1,895$62kNoticeSEC
Jun 2, 2023Jun 5, 2023Cerevel Therapeutics Holdings, Inc.OfficerForm 4 sale1,895$62k25.5%RoutineSEC